Essex Investment Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Essex Investment Management’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-7,863	Closed	-$232K	–	353
2015 Q4	$232K	Sell	7,863 -546	-6%	-$16.5K	0.04%	284
2015 Q3	$266K	Buy	8,409 +371	+5%	+$17.7K	0.04%	277
2015 Q2	$476K	Sell	8,038 -363	-4%	-$25.6K	0.07%	232
2015 Q1	$898K	Sell	8,401 -5,079	-38%	-$484K	0.13%	168
2014 Q4	$1.27M	Buy	13,480 +3,675	+37%	+$351K	0.18%	123
2014 Q3	$753K	Sell	9,805 -712	-7%	-$56.1K	0.12%	193
2014 Q2	$944K	Sell	10,517 -2,135	-17%	-$131K	0.14%	193
2014 Q1	$677K	Buy	+12,652	New	+$418K	0.1%	224

Other funds holding PTX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Essex Investment Management's PTX Position: Q1 2016 in Review

Essex Investment Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2016, closing a stake of 7,863 shares — an estimated $232K sold.

Essex Investment Management first reported a position in PTX in Q1 2014 and held it in 8 quarters. The position peaked at $1.27M in Q4 2014. 88 funds tracked by Wall St. Rank hold PTX as of Q1 2016.

Essex Investment Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2016 after selling out during the quarter.
Essex Investment Management sold 7,863 Pernix Therapeutics Holdings, Inc. shares in Q1 2016, an estimated $232K.
Essex Investment Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2014 and held it in 8 quarters.
Essex Investment Management's Pernix Therapeutics Holdings, Inc. position peaked at $1.27M in Q4 2014.
88 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2016.

Based on Essex Investment Management's 13F filing for Q1 2016, filed 9 May 2016.